Abstract:Background Tissue-engineered bone regeneration and osseointegration in extreme conditions still requires the regulation of additional growth factors or osteogenic drugs. Endowing Ti implants controlled growth factors osteogenic drugs delivery capability to stimulate specific cell gene responses at the molecular level and therefore promoting osteointegration and osteogenesis has become an emerging filed and has drawn tremendous attention. Metal-organic frameworks (MOFs) are good nanocarriers. Aim/Hypothesis In this work, we constructed a stable, effective, and sustainable DEX delivery platform on Ti disc by immobilizing DEX@zeolitic imidazolate framework-8 (DEX@ZIF-8) nanoparticles into the micrometer-scale artificial etch pits on Ti substrate. Material and Methods The morphology and particle size of the as-prepared DEX@ZIF-8 nanoparticles were investigated and the DEX loading encapsulation efficiency was determined, as well. Then, the surface morphology and DEX release behavior of the as-prepared Ti disc as well as the bonding strength of the SF membrane with the Ti substrate were investigated in detail. Besides, we also researched the barrier effect of the pit walls on the deposited drug carriers under the condition of simulated mechanical wear. The in vitro cell culture assay was performed by cultivating MC3T3-E1 cells on the Ti disc. Briefly, we investigated the adhesion, proliferation, differentiation, calcium deposition, osteogenic genes expressions of the adherent cells. Results Owing to the synergistic barrier effect of the ZIF-8 shell and the SF membrane, the SF-DEX@ZIF-8-Ti demonstrated controlled DEX release behavior over the following 30 days in phosphate buffer solution (PBS). In addition, the pit walls together with the SF membrane protected the DEX@ZIF-8 nanoparticles from detaching from the Ti substrate in the case of mechanical wear. The covalent interaction between the SF membrane and the Ti substrate prevented the SF membrane from self-peeling from the Ti substrate in moisture environment. In vitro cell culture indicated that the SF-DEX@ZIF-8-Ti had good cytocompatibility with MC3T3-E1 cells. Furthermore, the cells cultured on the SF-DEX@ZIF-8-Ti demonstrated higher differentiation, calcium deposition, and osteogenic genes expressions than the cells cultured on the SF-ZIF-8-Ti and pristine Ti. Conclusions and Clinical Implications In this work, ZIF-8, an emerging nano-sized drug carrier, found a novel application in bone implants. DEX was utilized as a drug model and could be replaced by other osteogenic drugs or growth factors. Thus, we believed that our design philosophy could inspire future research work in developing Ti implants for dental care and bone defect repair.

Rational Design of a Stable, Effective, and Sustainable Dexamethasone Delivery Platform on Ti Implant – an Innovative Application of Metal Organic Framework in Bone Implants

Fabrication and Biological Evaluation of the Coating Co‐doped Strontium and Zinc Nanoparticles on Porous Pure Titanium Surface by Hydrothermal Method

Biomimetic Metal−Organic Frameworks as Targeted Vehicles to Enhance Osteogenesis

Fabrication of Dexamethasone-Loaded Dual-Metal-Organic Frameworks on Polyetheretherketone Implants with Bacteriostasis and Angiogenesis Properties for Promoting Bone Regeneration.

The sustained release of dexamethasone from TiO2 nanotubes reinforced by chitosan to enhance osteoblast function and anti-inflammation activity

ZIF-8 nanoparticles combined with fibroin protein co-modified TiO 2 nanotube arrays to construct a drug sustained-release platform

Hybrid zinc oxide nanocoating on titanium implants: Controlled drug release for enhanced antibacterial and osteogenic performance in infectious conditions

Locally released dexamethasone and its effects on osteogenic activity at implant‐tissue interface

Dexamethasone Long-Term Controlled Release from Injectable Dual-Network Hydrogels with Porous Microspheres Immunomodulation Promotes Bone Regeneration

Synergistic Regulation of Osteoimmune Microenvironment by IL-4 and RGD to Accelerate Osteogenesis.

Porous hydroxyapatite scaffold with three-dimensional localized drug delivery system using biodegradable microspheres

In Situ Biomimetic Mineralization on ZIF-8 for Smart Drug Delivery

Activating Angiogenesis and Immunoregulation to Propel Bone Regeneration via Deferoxamine-Laden Mg-Mediated Tantalum Oxide Nanoplatform

A drug delivery system constructed by a fusion peptide capturing exosomes targets to titanium implants accurately resulting the enhancement of osseointegration peri-implant

Controlled release of dopamine coatings on titanium bidirectionally regulate osteoclastic and osteogenic response behaviors

Peptide LL-37 coating on micro-structured titanium implants to facilitate bone formation in vivo via mesenchymal stem cell recruitment

A novel vertical aligned mesoporous silica coated nanohydroxyapatite particle as efficient dexamethasone carrier for potential application in osteogenesis

Growth and accelerated differentiation of mesenchymal stem cells on graphene-oxide-coated titanate with dexamethasone on surface of titanium implants

Enhancing Osseointegration of TC4 Alloy by Surficial Activation Through Biomineralization Method

Synthetic nanointerfacial bioengineering of Ti implants: on-demand regulation of implant-bone interactions for enhancing osseointegration

Mesoporous TiO2 Coatings Regulate ZnO Nanoparticle Loading and Zn2+ Release on Titanium Dental Implants for Sustained Osteogenic and Antibacterial Activity.